|
Volumn 24, Issue 12, 2005, Pages 777-779
|
The management of infections due to drug-resistant gram-positive bacteria
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
AVOPARCIN;
BETA LACTAM ANTIBIOTIC;
CEFEPIME;
CEFTOBIPROLE;
CLINDAMYCIN;
COTRIMOXAZOLE;
DALBAVANCIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
DAPTOMYCIN;
GLYCOPEPTIDE;
LINEZOLID;
MACROLIDE;
ORITAVANCIN;
PENICILLIN G;
PIPERACILLIN PLUS TAZOBACTAM;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
TEICOPLANIN;
TELAVANCIN;
TIGECYCLINE;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
BACTERIAL VIRULENCE;
EDITORIAL;
GRAM POSITIVE BACTERIUM;
HOSPITAL INFECTION;
HUMAN;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MORTALITY;
NONHUMAN;
PENICILLIN RESISTANCE;
POLITICS;
PREVALENCE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
STREPTOCOCCUS PNEUMONIAE;
TREATMENT FAILURE;
VANCOMYCIN RESISTANT ENTEROCOCCUS;
VENTILATOR ASSOCIATED PNEUMONIA;
ANIMALS;
DISEASE MANAGEMENT;
DRUG RESISTANCE, BACTERIAL;
EVOLUTION;
GRAM-POSITIVE BACTERIA;
GRAM-POSITIVE BACTERIAL INFECTIONS;
HUMANS;
METHICILLIN RESISTANCE;
STAPHYLOCOCCUS AUREUS;
VANCOMYCIN RESISTANCE;
|
EID: 29944440080
PISSN: 09349723
EISSN: None
Source Type: Journal
DOI: 10.1007/s10096-005-0062-2 Document Type: Editorial |
Times cited : (9)
|
References (7)
|